Mary L. Anderson

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Mary L.
Anderson is Vice President of Business Development for Xoma Ltd., which she joined in February 2008.
She was Executive Director of Global Licensing and Business Development for Oncology at Merck-Serono International SA. Ms. Anderson has 20 years of experience in the pharmaceutical and biotechnology industry.
She was Senior Director of Corporate Development for MorphoSys AG, where she was charged with growing the antibody discovery business.
She also held business development positions at Agensys, Inc. and Bayer AG.
Ms. Anderson worked in Research for Chiron and Gen-Probe.
She received an MBA from St. Mary's College of California and a BS degree in Biochemistry from California Polytechnic State University at San Luis Obispo.

Precedenti posizioni note di Mary L. Anderson

Società	Posizione	Fine
Merck Serono SA Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.	Corporate Officer/Principal	-
XOMA CORPORATION	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Mary L. Anderson

Formazione di Mary L. Anderson

St. Mary's College of California	Masters Business Admin
California Polytechnic State University (San Luis Obispo)	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private